Medicinova (MNOV) Asset Utilization Ratio (2012 - 2025)

Medicinova's (MNOV) quarterly Asset Utilization Ratio came in at 0.01 in Q4 2025, down 65.96% on a QoQ basis from 0.03 in Q3 2025.

Medicinova (MNOV) Asset Utilization Ratio (2012 - 2025) Analysis & Trends

Medicinova (MNOV) has 7 years of Asset Utilization Ratio data on file, last reported at 0.01 in Q4 2025.

On a quarterly basis, Asset Utilization Ratio changed N/A year-over-year to 0.01 in Q4 2025; TTM through Dec 2025 was 0.01, a N/A change from a year earlier, with the FY2025 full-year figure at 0.01, changed N/A from the prior year.
Asset Utilization Ratio for Q4 2025 stood at 0.01, down from 0.03 in the prior quarter.
Over the last five years, Asset Utilization Ratio for MNOV reached as high as 0.12 in Q1 2021 and fell as low as 0.01 in Q4 2025.
Historically, Asset Utilization Ratio has averaged 0.04 across 3 years, with a median of 0.03 in 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Asset Util. (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	0.69
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	0.47
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	0.37
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Medicinova	64.48 Mn	64.48 Mn	4,754.00	0.01

Download Data